Commentary: Screening: righting a wrong in Auckland.

J Clin Epidemiol

Emeritus Professor of Haematology, Trinity College, University of Cambridge, Cambridge CB2 1TQ, UK; 1986 - 2003: Professor of Haematology, University of Cambridge & Head of Clinical Haematology, Addenbrooke's Hospital, Cambridge, UK; 1978- 1986: Professor of Molecular Pathology, Pathology Department, Christchurch School of Medicine, University of Otago, New Zealand. Electronic address:

Published: November 2020

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jclinepi.2020.09.001DOI Listing

Publication Analysis

Top Keywords

commentary screening
4
screening righting
4
righting wrong
4
wrong auckland
4
commentary
1
righting
1
wrong
1
auckland
1

Similar Publications

A Commentary On: Fehrenbach J, de Soares J L S, do Nascimento Foly J C S, Miotti L L, Münchow E A Mechanical performance of endocrown restorations in anterior teeth: A systematic review and network meta-analysis. Dent Mater 2025; https://doi.org/10.

View Article and Find Full Text PDF

Rethinking Pediatric Sepsis and Septic Shock: Beyond International Consensus Criteria.

Pediatric Health Med Ther

March 2025

Department of Pediatrics, Faculty of Clinical Medicine and Dentistry, Kampala International University Western Campus, Ishaka-Bushenyi, Uganda.

Purpose/objective: International pediatric sepsis consensus definitions play a critical role in evidence-based clinical practice, providing standardized tools for case identification. However, a common misconception is treating sepsis as a static diagnosis rather than recognizing it as a dynamic and evolving process. It is essential to integrate consensus criteria into a broader, more flexible clinical approach rather than applying them rigidly.

View Article and Find Full Text PDF

The 2022 KDIGO guideline for diabetes management in patients with chronic kidney disease (CKD) had endorsed the use of GLP-1 receptor agonists (GLP-1RAs) for patients with CKD and type 2 diabetes who did not achieve optimal glycemic target with maximally tolerated metformin and sodium-glucose co-transporter-2 (SGLT-2) inhibitor. Our study revealed the potential benefits of GLP-1RAs in patients with dialysis-requiring acute kidney disease possibly owing to pleiotropic effects of the medicine. Nonetheless, pharmacokinetics and dialysis dose were omitted in our subgroup analyses.

View Article and Find Full Text PDF

A Commentary On: Sukumar S, Rahmanyar Z, El Jurf H Q et al. Mapping the oral resistome: a systematic review. J Med Microbiol 2024; https://doi.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!